136 related articles for article (PubMed ID: 37380118)
1. Definitions, acceptability, limitations, and guidance in the use and reporting of surrogate end points in trials: a scoping review.
Manyara AM; Davies P; Stewart D; Weir CJ; Young AE; Wells V; Blazeby J; Butcher NJ; Bujkiewicz S; Chan AW; Collins GS; Dawoud D; Offringa M; Ouwens M; Ross JS; Taylor RS; Ciani O
J Clin Epidemiol; 2023 Aug; 160():83-99. PubMed ID: 37380118
[TBL] [Abstract][Full Text] [Related]
2. Scoping and targeted reviews to support development of SPIRIT and CONSORT extensions for randomised controlled trials with surrogate primary endpoints: protocol.
Manyara AM; Davies P; Stewart D; Wells V; Weir C; Young A; Taylor R; Ciani O
BMJ Open; 2022 Oct; 12(10):e062798. PubMed ID: 36229145
[TBL] [Abstract][Full Text] [Related]
3. Outcome reporting recommendations for clinical trial protocols and reports: a scoping review.
Butcher NJ; Mew EJ; Monsour A; Chan AW; Moher D; Offringa M
Trials; 2020 Jul; 21(1):620. PubMed ID: 32641085
[TBL] [Abstract][Full Text] [Related]
4. Guidelines for reporting pediatric and child health clinical trial protocols and reports: study protocol for SPIRIT-Children and CONSORT-Children.
Baba A; Smith M; Potter BK; Chan AW; Moher D; Offringa M
Trials; 2024 Jan; 25(1):96. PubMed ID: 38287439
[TBL] [Abstract][Full Text] [Related]
5. Protocol for the development of SPIRIT and CONSORT extensions for randomised controlled trials with surrogate primary endpoints: SPIRIT-SURROGATE and CONSORT-SURROGATE.
Manyara AM; Davies P; Stewart D; Weir CJ; Young A; Butcher NJ; Bujkiewicz S; Chan AW; Collins GS; Dawoud D; Offringa M; Ouwens M; Ross JS; Taylor RS; Ciani O
BMJ Open; 2022 Oct; 12(10):e064304. PubMed ID: 36220321
[TBL] [Abstract][Full Text] [Related]
6. Recommendations and evidence for reporting items in pediatric clinical trial protocols and reports: two systematic reviews.
Clyburne-Sherin AV; Thurairajah P; Kapadia MZ; Sampson M; Chan WW; Offringa M
Trials; 2015 Sep; 16():417. PubMed ID: 26385379
[TBL] [Abstract][Full Text] [Related]
7. Guidelines for Reporting Outcomes in Trial Protocols: The SPIRIT-Outcomes 2022 Extension.
Butcher NJ; Monsour A; Mew EJ; Chan AW; Moher D; Mayo-Wilson E; Terwee CB; Chee-A-Tow A; Baba A; Gavin F; Grimshaw JM; Kelly LE; Saeed L; Thabane L; Askie L; Smith M; Farid-Kapadia M; Williamson PR; Szatmari P; Tugwell P; Golub RM; Monga S; Vohra S; Marlin S; Ungar WJ; Offringa M
JAMA; 2022 Dec; 328(23):2345-2356. PubMed ID: 36512367
[TBL] [Abstract][Full Text] [Related]
8. Improving outcome reporting in clinical trial reports and protocols: study protocol for the Instrument for reporting Planned Endpoints in Clinical Trials (InsPECT).
Butcher NJ; Monsour A; Mew EJ; Szatmari P; Pierro A; Kelly LE; Farid-Kapadia M; Chee-A-Tow A; Saeed L; Monga S; Ungar W; Terwee CB; Vohra S; Fergusson D; Askie LM; Williamson PR; Chan AW; Moher D; Offringa M
Trials; 2019 Mar; 20(1):161. PubMed ID: 30841935
[TBL] [Abstract][Full Text] [Related]
9. SPIRIT and CONSORT extensions for early phase dose-finding clinical trials: the DEFINE (DosE-FIndiNg Extensions) study protocol.
Espinasse A; Solovyeva O; Dimairo M; Weir C; Jaki T; Mander A; Kightley A; Evans J; Lee S; Bedding A; Hopewell S; Rantell K; Liu R; Chan AW; De Bono J; Yap C
BMJ Open; 2023 Mar; 13(3):e068173. PubMed ID: 36990492
[TBL] [Abstract][Full Text] [Related]
10. Guidance for reporting outcomes in clinical trials: scoping review protocol.
Butcher NJ; Mew EJ; Saeed L; Monsour A; Chee-A-Tow A; Chan AW; Moher D; Offringa M
BMJ Open; 2019 Feb; 9(2):e023001. PubMed ID: 30782872
[TBL] [Abstract][Full Text] [Related]
11. Guidelines for Reporting Outcomes in Trial Reports: The CONSORT-Outcomes 2022 Extension.
Butcher NJ; Monsour A; Mew EJ; Chan AW; Moher D; Mayo-Wilson E; Terwee CB; Chee-A-Tow A; Baba A; Gavin F; Grimshaw JM; Kelly LE; Saeed L; Thabane L; Askie L; Smith M; Farid-Kapadia M; Williamson PR; Szatmari P; Tugwell P; Golub RM; Monga S; Vohra S; Marlin S; Ungar WJ; Offringa M
JAMA; 2022 Dec; 328(22):2252-2264. PubMed ID: 36511921
[TBL] [Abstract][Full Text] [Related]
12. A scoping review identifies multiple comments suggesting modifications to SPIRIT 2013 and CONSORT 2010.
Nejstgaard CH; Boutron I; Chan AW; Chow R; Hopewell S; Masalkhi M; Moher D; Schulz KF; Shlobin NA; Østengaard L; Hróbjartsson A
J Clin Epidemiol; 2023 Mar; 155():48-63. PubMed ID: 36669708
[TBL] [Abstract][Full Text] [Related]
13. Reporting Guidelines for Clinical Trial Protocols and Reports of Implantable Neurostimulation Devices: Protocol for the SPIRIT-iNeurostim and CONSORT-iNeurostim Extensions.
Duarte RV; Bresnahan R; Copley S; Eldabe S; Thomson S; North RB; Baranidharan G; Levy RM; Taylor RS;
Neuromodulation; 2022 Oct; 25(7):1045-1049. PubMed ID: 35088759
[TBL] [Abstract][Full Text] [Related]
14. A framework for the definition and interpretation of the use of surrogate endpoints in interventional trials.
Ciani O; Manyara AM; Davies P; Stewart D; Weir CJ; Young AE; Blazeby J; Butcher NJ; Bujkiewicz S; Chan AW; Dawoud D; Offringa M; Ouwens M; Hróbjartssson A; Amstutz A; Bertolaccini L; Bruno VD; Devane D; Faria CDCM; Gilbert PB; Harris R; Lassere M; Marinelli L; Markham S; Powers JH; Rezaei Y; Richert L; Schwendicke F; Tereshchenko LG; Thoma A; Turan A; Worrall A; Christensen R; Collins GS; Ross JS; Taylor RS
EClinicalMedicine; 2023 Nov; 65():102283. PubMed ID: 37877001
[TBL] [Abstract][Full Text] [Related]
15. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
16. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
[TBL] [Abstract][Full Text] [Related]
17. Reminding Peer Reviewers of Reporting Guideline Items to Improve Completeness in Published Articles: Primary Results of 2 Randomized Trials.
Speich B; Mann E; Schönenberger CM; Mellor K; Griessbach AN; Dhiman P; Gandhi P; Lohner S; Agarwal A; Odutayo A; Puebla I; Clark A; Chan AW; Schlussel MM; Ravaud P; Moher D; Briel M; Boutron I; Schroter S; Hopewell S
JAMA Netw Open; 2023 Jun; 6(6):e2317651. PubMed ID: 37294569
[TBL] [Abstract][Full Text] [Related]
18. Surrogate endpoints in trials: a call for better reporting.
Ciani O; Manyara AM; Chan AW; Taylor RS;
Trials; 2022 Dec; 23(1):991. PubMed ID: 36503559
[TBL] [Abstract][Full Text] [Related]
19. Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals.
Turner L; Shamseer L; Altman DG; Weeks L; Peters J; Kober T; Dias S; Schulz KF; Plint AC; Moher D
Cochrane Database Syst Rev; 2012 Nov; 11(11):MR000030. PubMed ID: 23152285
[TBL] [Abstract][Full Text] [Related]
20. Assessing the reporting quality of adult neuro-oncology protocols, abstracts, and trials: Adherence to the SPIRIT and CONSORT statements.
Suppree JS; Patel A; Keshwara SM; Krishna ST; Gillespie CS; Richardson GE; Mustafa MA; Hart S; Islim AI; Jenkinson MD; Millward CP
Neurooncol Pract; 2023 Aug; 10(4):391-401. PubMed ID: 37457230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
